Ufp Technologies (UFPT) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.01% |
| Dec 31, 2025 | 19.23% |
| Sep 30, 2025 | 52.18% |
| Jun 30, 2025 | 35.82% |
| Mar 31, 2025 | 24.18% |
| Dec 31, 2024 | 30.20% |
| Sep 30, 2024 | 15.83% |
| Jun 30, 2024 | 4.15% |
| Mar 31, 2024 | 31.83% |
| Dec 31, 2023 | 7.70% |
| Sep 30, 2023 | 27.24% |
| Jun 30, 2023 | -5.13% |
| Mar 31, 2023 | 33.42% |
| Dec 31, 2022 | 73.22% |
| Sep 30, 2022 | -23.78% |
| Jun 30, 2022 | -42.27% |
| Mar 31, 2022 | -32.44% |
| Dec 31, 2021 | -18.27% |
| Sep 30, 2021 | -3.17% |
| Jun 30, 2021 | 30.90% |
| Mar 31, 2021 | 19.82% |
| Dec 31, 2020 | 67.31% |
| Sep 30, 2020 | 38.01% |
| Jun 30, 2020 | -0.16% |
| Mar 31, 2020 | 18.98% |
| Dec 31, 2019 | 33.17% |
| Sep 30, 2019 | 47.24% |
| Jun 30, 2019 | 240.26% |
| Mar 31, 2019 | 24.07% |
| Dec 31, 2018 | 12.83% |
| Sep 30, 2018 | -1.75% |
| Jun 30, 2018 | 24.40% |
| Mar 31, 2018 | -25.12% |
| Dec 31, 2017 | -7.25% |
| Sep 30, 2017 | 7.12% |
| Jun 30, 2017 | -12.60% |
| Mar 31, 2017 | 43.56% |
| Dec 31, 2016 | 9.73% |
| Sep 30, 2016 | 5.62% |
| Jun 30, 2016 | -21.42% |
| Mar 31, 2016 | -66.36% |
| Dec 31, 2015 | -10.72% |
| Sep 30, 2015 | -21.71% |